{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:12:27Z","timestamp":1761664347318,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.dld.2021.12.014","type":"journal-article","created":{"date-parts":[[2021,12,26]],"date-time":"2021-12-26T22:32:49Z","timestamp":1640557969000},"page":"565-571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hepatocellular liver injury in hospitalized patients affected by COVID-19: Presence of different risk factors at different time points"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0581-4850","authenticated-orcid":false,"given":"M.","family":"Leo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Galante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pagnamenta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ruinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.R.","family":"Ponziani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"De Gottardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2021.12.014_bib0001","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2021.12.014_bib0002","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72\u00a0314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.dld.2021.12.014_bib0003","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S2468-1253(20)30126-6","article-title":"Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis","volume":"5","author":"Mao","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.12.014_bib0004","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jhep.2020.04.006","article-title":"COVID-19: abnormal liver function tests","volume":"73","author":"Cai","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.12.014_bib0005","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","volume":"395","author":"Huang","year":"2020","journal-title":"China. Lancet."},{"key":"10.1016\/j.dld.2021.12.014_bib0006","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/hep.31326","article-title":"Liver biochemistries in hospitalized patients with COVID-19","volume":"73","author":"Bloom","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.12.014_bib0007","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep.31404","article-title":"Acute liver injury in COVID-19: prevalence and association with clinical outcomes in a large U.S. cohort","volume":"72","author":"Phipps","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.12.014_bib0008","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2021.12.014_bib0009","first-page":"13072","article-title":"Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis","volume":"24","author":"Del Zompo","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.dld.2021.12.014_bib0010","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1136\/gutjnl-2020-321350","article-title":"Severe liver failure during SARS-CoV-2 infection","volume":"69","author":"Weber","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.dld.2021.12.014_bib0011","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","volume":"5","author":"Zhang","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.12.014_bib0012","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cld.967","article-title":"Interrelationship between coronavirus infection and liver disease","volume":"15","author":"Schaefer","year":"2020","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.dld.2021.12.014_bib0013","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1053\/j.gastro.2016.09.048","article-title":"Innate immune cell trafficking and function during sterile inflammation of the liver","volume":"151","author":"McDonald","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.12.014_bib0014","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/liv.14435","article-title":"Liver injury during highly pathogenic human coronavirus infections","volume":"40","author":"Xu","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.12.014_bib0015","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1164\/ajrccm.152.2.7633699","article-title":"Effects of PEEP on liver arterial and venous blood flows","volume":"152","author":"Brienza","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.dld.2021.12.014_bib0016","article-title":"Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection","author":"Chai","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.dld.2021.12.014_bib0017","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"key":"10.1016\/j.dld.2021.12.014_bib0018","first-page":"21","article-title":"General anatomy report of novel coronavirus pneumonia patients","volume":"36","author":"Liu","year":"2020","journal-title":"Journal of Forensic Medicine"},{"key":"10.1016\/j.dld.2021.12.014_bib0019","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2020.05.002","article-title":"SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19","volume":"73","author":"Wang","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.12.014_bib0020","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jhep.2020.05.025","article-title":"SARS-CoV-2 related liver impairment - perception may not be the reality","volume":"73","author":"Philips","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.12.014_bib0021","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.cgh.2020.04.002","article-title":"Clinical features of COVID-19-related liver functional abnormality","volume":"18","author":"Fan","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.12.014_bib0022","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/apt.15996","article-title":"Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients","volume":"52","author":"Ponziani","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2021.12.014_bib0023","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jhep.2020.12.012","article-title":"Association of liver abnormalities with in-hospital mortality in patients with COVID-19","volume":"74","author":"Ding","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.12.014_bib0024","unstructured":"National Institutes of Health, National Cancer Institute, U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf. Published November 27, 2017."},{"key":"10.1016\/j.dld.2021.12.014_bib0025","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.dld.2021.12.014_bib0026","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/hep.31301","article-title":"Longitudinal association between markers of liver injury and mortality in COVID-19 in China","volume":"72","author":"Lei","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.12.014_bib0027","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jhep.2020.03.044","article-title":"Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study","volume":"73","author":"Ji","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.12.014_bib0028","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/jgh3.12395","article-title":"Hepatic steatosis as an independent risk factor for severe disease in patients with COVID-19: a computed tomography study","volume":"4","author":"Palomar-Lever","year":"2020","journal-title":"JGH Open"},{"key":"10.1016\/j.dld.2021.12.014_bib0029","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.12.014_bib0030","first-page":"212","article-title":"Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity","volume":"3","author":"Massart","year":"2017","journal-title":"J Clin Transl Res"},{"key":"10.1016\/j.dld.2021.12.014_bib0031","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.chest.2017.08.018","article-title":"Cholestatic Alterations in the Critically Ill: some New Light on an Old Problem","volume":"153","author":"Jenniskens","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.dld.2021.12.014_bib0032","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/hep.31480","article-title":"Abnormal liver function tests in patients with COVID-19: relevance and potential pathogenesis","volume":"72","author":"Bertolini","year":"2020","journal-title":"Hepatology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821009233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821009233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:19:56Z","timestamp":1761625196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865821009233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1590865821009233"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2021.12.014","relation":{},"ISSN":["1590-8658"],"issn-type":[{"type":"print","value":"1590-8658"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocellular liver injury in hospitalized patients affected by COVID-19: Presence of different risk factors at different time points","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2021.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}